REG - Santander UK Plc - Issue 1206 Article 17 notification

Banco Santander SAAnnouncement

01/07/2022 11:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220701:nRSA0025Ra&default-theme=true

RNS Number : 0025R  Santander UK Plc  01 July 2022

ARTICLE 17 NOTIFICATION

 

Santander UK plc (the "Issuer")

 

 

This notification refers to:

 

(1)        the Base Prospectus dated 18 March 2022, as supplemented
from time to time (the Base Prospectus) for Notes to be issued by the Issuer
under its Structured Note and Certificate Programme; and

 

(2)        the Final Terms dated 29 April 2022 (the Final Terms) in
respect of the issue of up to £20,000,000 Preference Share-linked
Autocallable Notes due 2028 - Series 1206 (XS2463895784) (the Note Issue).

 

Pursuant to our obligations under Article 17 of the Prospectus Regulation
(Regulation 2017/1129/EU, as amended and as incorporated into the law of the
United Kingdom by the European Union (Withdrawal) Act 2018, as amended) we
confirm in respect of the Note Issue the following information:

 

Final Aggregate Nominal Amount:          £1,292,500

 

Paragraphs 4.1 and 4.2 of Part A to the Final Terms shall be read accordingly.

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Base Prospectus and the
Final Terms may be addressed to and/or targeted at persons who are residents
of particular countries (specified in the Base Prospectus and/or the Final
Terms) only and is not intended for use and should not be relied upon by any
person outside these countries and/or to whom the offer contained in the Base
Prospectus and/or the Final Terms is not addressed. Prior to relying on the
information contained in the Base Prospectus and/or the Final Terms, you must
ascertain from the Base Prospectus and/or the Final Terms whether or not you
are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above
requirement.

Neither the Base Prospectus nor the Final Terms referenced herein constitute
an offer of securities for sale in the United States. The securities described
herein have not been, and will not be, registered under the U.S. Securities
Act of 1933, as amended (the "Securities Act"), or under any relevant
securities laws of any state of the United States of America, and may not be
offered or sold to U.S. persons or to persons within the United States of
America, except pursuant to an exemption from the Securities Act.

 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DOCRBMLTMTMMMBT